Paper12757706
The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases.
Cosma MP and 6 others. Cell, 2003. Cited by 275 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases. Papers, record 12757706. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12757706
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The multiple sulfatase deficiency gene encodes an essential and limiting factor for the activity of sulfatases.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gene Expression Regulation, Enzymologic | Major topic |
| Mutation | Major topic |
| Sphingolipidoses | Major topic |
| Sulfatases | Major topic |
| Animals | |
| COS Cells | |
| Chromosomes, Human, Pair 3 | |
| DNA, Complementary | |
| Evolution, Molecular | |
| Humans | |
| Mice | |
| Molecular Sequence Data | |
| Protein Structure, Tertiary | |
| Sequence Homology, Amino Acid | |
| Sequence Homology, Nucleic Acid |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| TGM03S01 | Telethon | Italy | PubMed | |
| TGM06S01 | Telethon | Italy | PubMed |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 12757700 | A major step on the road to understanding a unique posttranslational modification and its role in a genetic disease. | https://conductscience.org/library/papers/12757700 |
Source PubMed
Cited by138
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 275 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42724099 | Dysregulated cholesterol metabolism in genodermatoses: implications for systemic disease and therapeutic strategies. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42724099 | PubMed |
| 41783940 | Development and characterization of a model of mucopolysaccharidosis type IVA for evaluating therapies targeting bone disease. | Dis Model Mech | 2026 | https://conductscience.org/library/papers/41783940 | PubMed |
| 41614773 | Mapping Lysosomal Storage Disorders with Neurological Features by Cellular Pathways: Towards Precision Medicine. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/41614773 | PubMed |
| 41315317 | A scoping review of stem cell models of leukodystrophies: advances in understanding pathophysiological mechanisms. | NPJ Genom Med | 2025 | https://conductscience.org/library/papers/41315317 | PubMed |
| 41213165 | Copper in Human Health and Disease: Insights from Inherited Disorders. | Physiology (Bethesda) | 2026 | https://conductscience.org/library/papers/41213165 | PubMed |
| 41155512 | SUMF1 Common Variant rs793391 Is Associated with Response to Inhaled Corticosteroids in Patients with COPD. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41155512 | PubMed |
| 39870870 | Preclinical use of a clinically-relevant scAAV9/SUMF1 vector for the treatment of multiple sulfatase deficiency. | Commun Med (Lond) | 2025 | https://conductscience.org/library/papers/39870870 | PubMed |
| 39789203 | Bone marrow transplantation reverses metabolic alterations in multiple sulfatase deficiency: a case series. | Commun Med (Lond) | 2025 | https://conductscience.org/library/papers/39789203 | PubMed |
| 39481371 | Entering the playing field: Therapy for multiple sulfatase deficiency. | Mol Ther | 2024 | https://conductscience.org/library/papers/39481371 | PubMed |
| 39448727 | Bone marrow transplantation increases sulfatase activity in somatic tissues in a multiple sulfatase deficiency mouse model. | Commun Med (Lond) | 2024 | https://conductscience.org/library/papers/39448727 | PubMed |
| 39169621 | Hematopoietic stem cell gene therapy improves outcomes in a clinically relevant mouse model of multiple sulfatase deficiency. | Mol Ther | 2024 | https://conductscience.org/library/papers/39169621 | PubMed |
| 38540990 | The Genetics behind Sulfation: Impact on Airway Remodeling. | J Pers Med | 2024 | https://conductscience.org/library/papers/38540990 | PubMed |
| 38161139 | A novel iPSC model reveals selective vulnerability of neurons in multiple sulfatase deficiency. | Mol Genet Metab | 2024 | https://conductscience.org/library/papers/38161139 | PubMed |
| 37732042 | The effect of intravenous trehalose administration in a patient with multiple sulfatase deficiency. | Arch Med Sci | 2023 | https://conductscience.org/library/papers/37732042 | PubMed |
| 37014547 | Characterization of a HIR-Fab-IDS, Novel Iduronate 2-Sulfatase Fusion Protein for the Treatment of Neuropathic Mucopolysaccharidosis Type II (Hunter Syndrome). | BioDrugs | 2023 | https://conductscience.org/library/papers/37014547 | PubMed |
| 36891126 | Transcription factor EB as a key molecular factor in human health and its implication in diseases. | SAGE Open Med | 2023 | https://conductscience.org/library/papers/36891126 | PubMed |
| 36789546 | Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency. | EMBO Mol Med | 2023 | https://conductscience.org/library/papers/36789546 | PubMed |
| 36482027 | The Effects of N-Acetyl-L-Leucine on the Improvement of Symptoms in a Patient with Multiple Sulfatase Deficiency. | Cerebellum | 2023 | https://conductscience.org/library/papers/36482027 | PubMed |
| 36441600 | Genetic analysis of a novel SUMF1 variation associated with a late infantile form of multiple sulfatase deficiency. | J Clin Lab Anal | 2022 | https://conductscience.org/library/papers/36441600 | PubMed |
| 36433920 | New mouse models with hypomorphic SUMF1 variants mimic attenuated forms of multiple sulfatase deficiency. | J Inherit Metab Dis | 2023 | https://conductscience.org/library/papers/36433920 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| LOC100130207 | 100130207 | Swiss-Prot's references | https://conductscience.org/library/genes/100130207 | NCBI Gene |
| SUMF1 | 285362 | Swiss-Prot's references | https://conductscience.org/library/genes/285362 | NCBI Gene |
| SUMF2 | 25870 | Swiss-Prot's references | https://conductscience.org/library/genes/25870 | NCBI Gene |
Data2
The data bank entries PubMed's record names. Trial numbers are under Trials.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- References
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/12757706
GET https://conductscience.org/api/papers/v1/12757706/cited_by?page=2